How To Test For Spirometry
|
|
|
- Lenard Jones
- 5 years ago
- Views:
Transcription
1 Confirming Diagnosis Through Spirometry Shirley F. Jones, M.D., FCCP I have no conflicts of interest Instructional Objectives At the end of this session, learners will be able to: Select individual patients appropriate for screening (case-finding) with spirometry. Differentiate between normal, obstructive, and restrictive spirogram patterns.
2 Recommendations From the National Lung Health Education Program Primary care clinicians should perform an office spirometry test for the following patients: Patients 45 years old who report smoking (current smokers and those who recently quit) in order to detect COPD. Patients with respiratory symptoms, such as chronic cough, sputum production, wheezing, or dyspnea on exertion. Ferguson et al. Chest. 2000;117: Old Spirometer New Spirometers: Portable Office Spirometers
3 Predicted Normal Values Affected by: Age Height Sex Ethnic Origin What Is Normal? Criteria for Normal Postbronchodilator Spirometry : % predicted 80% FVC: % predicted 80% /FVC: 0.7
4 Spirometric Diagnosis of COPD COPD is confirmed by postbronchodilator /FVC < 0.7. Postbronchodilator /FVC measured minutes after 2 to 4 puffs of a short-acting bronchodilator. Normal Trace Showing and FVC Volume, liters FVC = 4L (90% predicted) FVC = 5L (95% predicted) /FVC = Time, seconds
5 Spirometry: : Obstructive Disease 5 Volume, liters Normal = 1.8L (65% predicted) FVC = 3.2L (80% predicted) /FVC = 0.56 Obstructive Time, seconds ARS: A positive bronchodilator response differentiates between patients with asthma and COPD 1)True 2) False 3) Not Sure 55% 39% 6% 1 2 3
6 Airflow Obstruction in COPD Is Partially Reversible 15 * Degree of Reversibility Patients, % 10 5 *65.6% showed a 15% increase in Change in % Postbronchodilator measured after administration of 80 µg ipratropium and 400 µg albuterol. Adapted with permission from Tashkin DP, et al. Eur Resp J. 2008; 31: Bronchodilator Reversibility Testing Provides the best achievable (and FVC) Must be interpreted with clinical history - neither asthma nor COPD are diagnosed on spirometry alone
7 Significant Bronchodilator Response increases by 200 ml and increases by 12% Flow Volume Loop Included with most commercial spirometers Generates and FVC measurements Depicts expiration and inspiration Clear and rapidly recognizable patterns Obstructive disease (eg, asthma, COPD) Restrictive disease Upper airway obstruction
8 Expiratory flow rate, L/sec Flow Volume Curve Maximum expiratory flow (PEF) TLC FVC RV Inspiratory flow rate, L/sec Volume, L Flow Volume Curve Patterns Obstructive and Restrictive Obstructive Severe Obstructive Restrictive Expiratory flow rate Volume, L Expiratory flow rate Volume, L Expiratory flow rate Volume, L Reduced peak flow, scooped out midcurve Steeple pattern, reduced peak flow, rapid fall off Normal shape, normal peak flow, reduced volume
9 Flow Volume Loop Spirometry Is a Useful Tool To Assess COPD Severity and Progression 1,2 Postbronchodilator is recommended for the diagnosis and assessment of COPD /FVC < % predicted /FVC < % < 80% predicted /FVC < % < 50% predicted /FVC < 0.70 <30% predicted I: Mild II: Moderate III: Severe IV: Very Severe 1. American Thoracic Society, European Respiratory Society. Standards for the diagnosis and management of patients with COPD. Accessed November 19, Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated Global Initiative for Chronic Obstructive Lung Disease (GOLD). NHLBI/WHO Workshop report (updated 2006). (accessed March 14,2007)
10 Repeatability - Quality of Results Volume, liters Time, seconds Three times FVC within 5% or 0.15L (150 ml) ARS: How many trials are allowed by a single person per testing period to achieve repeatability? 1) 3 2) 6 47% 3) 8 30% 4) 12 5) as many as takes to get it right 10% 13% 0%
11 Nonrepeatablity Test Volume (L) Three Acceptable Maneuvers #3 #2 Curve FVC #1 1.0 # # # Time (s) American Thoracic Society. Am J Respir Crit Care Med. 1995;152: Official journal of the American Thoracic Society. American Lung Association. Reprinted with permission. ARS: Does this spirogram pass repeatability? 1) Yes 2) No 62% 3) Not sure 24% 14% 1 2 3
12 Summary Spirometry is the gold standard for diagnosing COPD and monitoring its progression. All patients 45 years old with a smoking history and all patients with respiratory symptoms, such as chronic productive cough, sputum production, and dyspnea, should be considered for spirometry. Spirometry requires accurate equipment, good test procedures, appropriate reference values, and proper interpretation. 1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Updated Available at: Accessed October 14, Audience Participation Please write down one thing you will do differently, apply, or search for additional information on as a result of what you learned in this presentation.
SPIROMETRY FOR HEALTH CARE PROVIDERS Global Initiative for Chronic Obstructive Lung Disease (GOLD)
SPIROMETRY FOR HEALTH CARE PROVIDERS Global Initiative for Chronic Obstructive Lung Disease (GOLD) CONTENTS I. INTRODUCTION II. BACKGROUND INFORMATION A. What Is Spirometry? B. Why Perform Spirometry?
PULMONARY FUNCTION TESTS A Workshop on Simple Spirometry & Flow Volume Loops
PULMONARY FUNCTION TESTS A Workshop on Simple Spirometry & Flow Volume Loops YOU SHOULD READ THE FOLLOWING MATERIAL BEFORE Tuesday March 30 Interpretation of PFTs Learning Objectives 1. Specify the indications
Interpretation of Pulmonary Function Tests
Interpretation of Pulmonary Function Tests Dr. Sally Osborne Cellular & Physiological Sciences University of British Columbia Room 3602, D.H Copp building 604 822-3421 [email protected] www.sallyosborne.com
Tests. Pulmonary Functions
Pulmonary Functions Tests Static lung functions volumes Dynamic lung functions volume and velocity Dynamic Tests Velocity dependent on Airway resistance Resistance of lung tissue to change in shape Dynamic
Spirometry Workshop for Primary Care Nurse Practitioners
Spirometry Workshop for Primary Care Nurse Practitioners Catherine Casey S. Jones PhD, RN, AE-C, ANP-C Certified Adult Nurse Practitioner Texas Pulmonary & Critical Care Consultants P.A. and Visiting Assistant
Forced vital capacity: maximal volume of air exhaled with maximally forced effort from a maximal inspiration.
SOP Spirometry 1. General considerations Spirometry serves as a physiological test to quantify pulmonary disease severity and to assess clinical change in respiratory function over time. Standard spirometric
COVER PAGE FOR the PDF file of PULMONARY FUNCTION TESTING
Page 1 of 11 COVER PAGE FOR the PDF file of PULMONARY FUNCTION TESTING This Pulmonary Function Testing file was found simply by doing an Internet word search of the phrase pulmonary function testing. It
COPD and Asthma Differential Diagnosis
COPD and Asthma Differential Diagnosis Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in America. Learning Objectives Use tools to effectively diagnose chronic obstructive
RES/006/APR16/AR. Speaker : Dr. Pither Sandy Tulak SpP
RES/006/APR16/AR Speaker : Dr. Pither Sandy Tulak SpP Definition of Asthma (GINA 2015) Asthma is a common and potentially serious chronic disease that imposes a substantial burden on patients, their families
Pathway for Diagnosing COPD
Pathway for Diagnosing Visit 1 Registry Clients at Risk Patient presents with symptoms suggestive of Exertional breathlessness Chronic cough Regular sputum production Frequent bronchitis ; wheeze Occupational
Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms
Clinical Guideline Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians,
Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms
Clinical Guideline Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians,
Bronchodilators in COPD
TSANZSRS Gold Coast 2015 Can average outcomes in COPD clinical trials guide treatment strategies? Long live the FEV1? Christine McDonald Dept of Respiratory and Sleep Medicine Austin Health Institute for
Chronic obstructive pulmonary
COVER ARTICLE OFFICE PROCEDURES An Approach to Interpreting Spirometry TIMOTHY J. BARREIRO, D.O., and IRENE PERILLO, M.D. University of Rochester School of Medicine and Dentistry, Rochester, New York Spirometry
RESPIRATORY VENTILATION Page 1
Page 1 VENTILATION PARAMETERS A. Lung Volumes 1. Basic volumes: elements a. Tidal Volume (V T, TV): volume of gas exchanged each breath; can change as ventilation pattern changes b. Inspiratory Reserve
SPIROMETRY IN PRACTICE
Spirometry_168x244_stg5 14/4/05 12:48 PM Page 2 SPIROMETRY IN PRACTICE A PRACTICAL GUIDE TO USING SPIROMETRY IN PRIMARY CARE Second Edition Spirometry_168x244_stg5 14/4/05 12:48 PM Page 3 Written by Dr
PLAN OF ACTION FOR. Physician Name Signature License Date
PLAN OF ACTION FOR Patient s copy (patient s name) I Feel Well Lignes I feel short directrices of breath: I cough up sputum daily. No Yes, colour: I cough regularly. No Yes I Feel Worse I have changes
National Learning Objectives for COPD Educators
National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators The COPD Educator will be able to achieve the following objectives. Performance objectives, denoted by the
Understanding Pulmonary Function Testing. PFTs, Blood Gases and Oximetry Skinny Little Reference Guide
Understanding Pulmonary Function Testing PFTs, Blood Gases and Oximetry Skinny Little Reference Guide INTRODUCTION This brochure is intended to help you understand the meaning of Pulmonary Function Testing,
Asthma COPD and Asthma - COPD Overlap Syndrome (ACOS)
Diagnosis of Diseases of Chronic Airflow Limitation: Asthma COPD and Asthma - COPD Overlap Syndrome (ACOS) Based on the Global Strategy for Asthma Management and Prevention and the Global Strategy for
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Development of disability in COPD The decline in airway function may initially go unnoticed as people adapt their lives to avoid
Sponsor Novartis Pharmaceuticals
Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Generic Drug Name Indacaterol Therapeutic Area of Trial Chronic Obstructive Pulmonary Disease (COPD) Indication studied: COPD Study
Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing
Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing ASBESTOSIS November 2013 Bruce T. Bishop Lucy L. Brandon Willcox & Savage 440
COPD. Information brochure for chronic obstructive pulmonary disease.
COPD Information brochure for chronic obstructive pulmonary disease. CONTENTS What does COPD mean?...04 What are the symptoms of COPD?...06 What causes COPD?...09 Treating COPD...10 Valve therapy in COPD...12
Asthma COPD and Asthma - COPD Overlap Syndrome (ACOS)
Diagnosis of Diseases of Chronic Airflow Limitation: Asthma COPD and Asthma - COPD Overlap Syndrome (ACOS) Based on the Global Strategy for Asthma Management and Prevention and the Global Strategy for
Chronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) is the name for a group of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways
An Overview of Asthma - Diagnosis and Treatment
An Overview of Asthma - Diagnosis and Treatment Asthma is a common chronic disorder of the airways that is complex and characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness,
COPD PROTOCOL CELLO. Leiden
COPD PROTOCOL CELLO Leiden May 2011 1 Introduction This protocol includes an explanation of the clinical picture, diagnosis, objectives and medication of COPD. The Cello way of working can be viewed on
This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical
Severe asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital
Severe asthma Definition, epidemiology and risk factors Mina Gaga Athens Chest Hospital Difficult asthma Defined as asthma, poorly controlled in terms of chronic symptoms, with episodic exacerbations,
Pulmonary Disorders. Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease (COPD)
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Pulmonary Disorders Chronic Obstructive Pulmonary Disease (COPD) Characterized by decreased expiratory airflow Reduction in expiratory
Pulmonary Rehab FAQ s (Abstracted from AACVPR site)
(Abstracted from AACVPR site) MAC J-15 Committee 1) Q: Is the 36 session PR program once in a lifetime or per calendar year or per event? Answer: CMS does not limit to one PR course to a calendar year.
A Guide to Performing Quality Assured Diagnostic Spirometry
A Guide to Performing Quality Assured Diagnostic Spirometry PCC Contents 1. Introduction 4 2. Performing Spirometry 6 3. Interpreting and Reporting of Results 10 4. TOP TEN TIPS for reporting spirometry
On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
Airways Resistance and Airflow through the Tracheobronchial Tree
Airways Resistance and Airflow through the Tracheobronchial Tree Lecturer: Sally Osborne, Ph.D. Department of Cellular & Physiological Sciences Email: [email protected] Useful links: www.sallyosborne.com
Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital
Mahidol University Journal of Pharmaceutical Sciences 008; 35(14): 81. Original Article Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital
Coding Guidelines for Certain Respiratory Care Services July 2014
Coding Guidelines for Certain Respiratory Care Services Overview From time to time the AARC receives inquiries about respiratory-related coding and coverage issues through its Help Line or Coding Listserv.
COPD. What is COPD? How many people have COPD in Canada? Who gets COPD?
What is COPD? COPD stands for Chronic Obstructive Pulmonary Disease. It is a long-term lung disease that makes it difficult for air to move into and out of the lungs. COPD is used to describe a few lung
Global Initiative for Chronic Obstructive Lung Disease
Global Initiative for Chronic Obstructive Lung Disease POCKET GUIDE TO COPD DIAGNOSIS, MANAGEMENT, AND PREVENTION A Guide for Health Care Professionals REVISED 2011 Global Initiative for Chronic Obstructive
These factors increase your chance of developing emphysema. Tell your doctor if you have any of these risk factors:
Emphysema Pronounced: em-fiss-see-mah by Debra Wood, RN En Español (Spanish Version) Definition Emphysema is a chronic obstructive disease of the lungs. The lungs contain millions of tiny air sacs called
Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)
Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Geisinger Health System Case Study Organization Profile Geisinger Health System is a physician-led, fully integrated
Calculating gambling odds and lung ages for smokers
Eur Respir J ; 3: 776 78 DOI:.1183/931936.779 CopyrightßERS Journals Ltd Calculating gambling odds and lung ages for smokers J.E. Hansen, X-G. Sun and K. Wasserman ABSTRACT: Interpreting spirometry as
2.06 Understand the functions and disorders of the respiratory system
2.06 Understand the functions and disorders of the respiratory system 2.06 Understand the functions and disorders of the respiratory system Essential questions What are the functions of the respiratory
Pulmonary Function Testing: Coding and Billing Issues
Pulmonary Function Testing: Coding and Billing Issues Neil R MacIntyre MD FAARC and Catherine M Foss CPFT Introduction Accreditation Developing Coding/Billing Strategies Spirometry Lung Volume Testing
Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care
Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care Charley P. Starnes, RRT, RCP Clinical Respiratory Specialist- COPD Education Important Milestones July 2011-
30 DAY COPD READMISSIONS AND PULMONARY REHAB
30 DAY COPD READMISSIONS AND PULMONARY REHAB Trina M. Limberg, Bs, RRT, FAARC, MAACVPR Director, Preventative Pulmonary and Rehabilitation Services UC San Diego Health System OVERVIEW The Impact of COPD
Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)
Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) DuPage Medical Group Case Study Organization Profile Established in 1999, DuPage Medical Group (DMG) is a multispecialty
Insights for Improvement: Advancing COPD Care Through Quality Measurement. An NCQA Insights for Improvement Publication
2009 Insights for Improvement: Advancing COPD Care Through Quality Measurement An NCQA Insights for Improvement Publication Chronic obstructive pulmonary disease (COPD) includes chronic bronchitis, emphysema,
written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd
written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd What Is COPD? COPD stands for chronic obstructive pulmonary disease. There are two major diseases included in
This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical
Objectives COPD. Chronic Obstructive Pulmonary Disease (COPD) 4/19/2011
Objectives Discuss assessment findings and treatment for: Chronic Obstructive Pulmonary Disease Bronchitis Emphysema Asthma Anaphylaxis Other respiratory issues Provide some definitions Chronic Obstructive
Medical Policy An independent licensee of the Blue Cross Blue Shield Association
Afrezza Page 1 of 6 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Afrezza (human insulin) Prime Therapeutics will review Prior Authorization requests Prior Authorization
Improvement in Dyspnea Implementing Pulmonary Rehabilitation in the Home
Improvement in Dyspnea Implementing Pulmonary Rehabilitation in the Home Mary Cesarz MS, PT Lisa Gorski MS, APRN, BC, FAAN Wheaton Franciscan Home Health & Hospice Milwaukee, WI Objectives To identify
Abnormalities Consistent with Asbestos-Related Disease Among Long-Term Demolition Workers
Abnormalities Consistent with Asbestos-Related Disease Among Long-Term Demolition Workers Stephen M. Levin, M.D. Mount Sinai School of Medicine New York, New York November 1994 The Center to Protect Workers
Exploratory data: COPD and blood eosinophils. David Price: 9.23-9.35am
Exploratory data: COPD and blood eosinophils David Price: 9.23-9.35am Blood Eosinophilia in COPD The reliability and utility of blood eosinophils as a marker of disease burden, healthcare resource utilisation
Management of Asthma
Federal Bureau of Prisons Clinical Practice Guidelines May 2013 Clinical guidelines are made available to the public for informational purposes only. The Federal Bureau of Prisons (BOP) does not warrant
MILITARY (ACTIVE DUTY)-SPECIFIC ISSUES
RECOMMENDATIONS MILITARY (ACTIVE DUTY)-SPECIFIC ISSUES Evaluation for possible asthma 1. Active duty service members should be diagnosed with asthma or exerciseinduced bronchospasm on the basis of the
Prevention of Acute COPD exacerbations
December 3, 2015 Prevention of Acute COPD exacerbations George Pyrgos MD 1 Disclosures No funding received for this presentation I have previously conducted clinical trials with Boehringer Ingelheim. Principal
ASTHMA IN INFANTS AND YOUNG CHILDREN
ASTHMA IN INFANTS AND YOUNG CHILDREN What is Asthma? Asthma is a chronic inflammatory disease of the airways. Symptoms of asthma are variable. That means that they can be mild to severe, intermittent to
Respiratory Concerns in Children with Down Syndrome
Respiratory Concerns in Children with Down Syndrome Paul E. Moore, M.D. Associate Professor of Pediatrics and Pharmacology Director, Pediatric Allergy, Immunology, and Pulmonary Medicine Vanderbilt University
Documenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC
Documenting & Coding Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC Sr. Provider Training & Development Consultant Professional Profile David Brigner currently performs
COPD It Can Take Your Breath Away www.patientedu.org
written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org What Is COPD? COPD stands for chronic obstructive pulmonary disease. There are 2 major diseases included in COPD:
An Outcomes Strategy for COPD and Asthma: NHS Companion Document
An Outcomes Strategy for COPD and Asthma: NHS Companion Document 1 DH INFORMATION READER BOX Policy Clinical Estates HR / Workforce Commissioner Development IM & T Management Provider Development Finance
COPYRIGHTED MATERIAL - DO NOT ALTER OR REPRODUCE GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION. Updated 2015. 2015 Global Initiative for Asthma
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION Updated 2015 2015 Global Initiative for Asthma Global Strategy for Asthma Management and Prevention The GINA reports are available on www.ginasthma.org.
CMAG. CASE MANAGEMENT ADHERENCE GUIDELINES VERSION 1.0 Chronic Obstructive Pulmonary Disease
CMAG CASE MANAGEMENT ADHERENCE GUIDELINES VERSION 1.0 Chronic Obstructive Pulmonary Disease Guidelines from the Case Management Society of America for improving patient adherence to COPD therapies April
The patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.
Emergency Room Asthma Management Algorithm The Emergency Room Asthma Management Algorithm is to be used for any patient seen in the Emergency Room with the diagnosis of asthma. (The initial history should
COPD Prescribing Guidelines
South Staffordshire Area Prescribing Group COPD Prescribing Guidelines Inhaler choices in this guideline are different from previous versions produced by the APG. It is not expected patients controlled
NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
MicroLab. The world s most versatile. portable Spirometer
MicroLab The world s most versatile portable Spirometer MicroLab A new generation Spirometer designed for Child incentive animatio the professional Developed for the professional, the new generation MicroLab
Department of Surgery
What is emphysema? 2004 Regents of the University of Michigan Emphysema is a chronic disease of the lungs characterized by thinning and overexpansion of the lung-like blisters (bullae) in the lung tissue.
Original Contribution
American Journal of Epidemiology Copyright ª 2006 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A. Vol. 165, No. 4 DOI: 10.1093/aje/kwk026 Advance Access publication
Reducing COPD Readmissions and Implications for Pulmonary Rehab. Janie Knipper, APN, MA, AE-C, FAACVPR [email protected]
Reducing COPD Readmissions and Implications for Pulmonary Rehab Janie Knipper, APN, MA, AE-C, FAACVPR [email protected] Statement of Disclosure I have no disclosures. The opinions expressed are my
1 ALPHA-1. What is Alpha-1? A family history... of lung disease? of liver disease? FOUNDATION
What is Alpha-1? A family history... of lung disease? of liver disease? What you need to know about Alpha-1 Antitrypsin Deficiency 1 ALPHA-1 FOUNDATION What is Alpha-1? Alpha-1 Antitrypsin Deficiency (Alpha-1)
3/11/15. COPD Disease Management Tackling the Transition. Objectives. Describe the multidisciplinary approach to inpatient care for COPD patients
Faculty Disclosures COPD Disease Management Tackling the Transition Dr. Cappelluti has no actual or potential conflicts of interest associated with this presentation. Jane Reardon has no actual or potential
CLINICAL USE OF PULSE OXIMETRY
CLINICAL USE OF PULSE OXIMETRY POCKET REFERENCE 2010 INTERNATIONAL Helping the World Breathe Free TM GLOBAL PRIMARY CARE AND PATIENT EDUCATION THE PURPOSE OF THIS GUIDE Chronic respiratory diseases such
Topic: New Treatment = Better Outcome?
Session on COPD: Novel Concepts and Promising New Drugs Topic: New Treatment = Better Outcome? Through a CME Grant sponsored by New Treatment = Better Outcome? Tim S. Trinidad, MD Disclosure Present: COPD
CLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease
CLINICAL PATHWAY Acute Medicine Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Table of Contents (tap to jump to page) INTRODUCTION 1 Scope of this Pathway 1 Pathway Contacts
